Lucid Diagnostics Inc.
LUCDDrugs in Pipeline
0
Phase 3 Programs
0
Upcoming Catalysts
2
Next Catalyst
Aug 13, 2026
9dMarket Overview
Stock performance and key metrics
2 upcoming, 0 past
LUCD Earnings Report
EPS Est: $-0.05 | FQ end 2026-06 | Call: 2026-08-13 15:00:00
Conference
Lucid Diagnostics announced a second quarter 2026 business update conference call and webcast scheduled for August 13, 2026 at 8:30 AM ET. The company is a cancer prevention medical diagnostics subsidiary of PAVmed Inc.
SourceHow LUCD's past catalysts played out
No drugs found in this phase.
Full breakdown — the signals behind the verdict
Frequently asked questions
When is Lucid Diagnostics Inc.'s next FDA catalyst?→
Lucid Diagnostics Inc.'s (LUCD) next tracked catalyst is a Earnings expected August 13, 2026. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.
How do I track LUCD biotech catalysts?→
Add LUCD to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Lucid Diagnostics Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.